TO THE EDITOR: I read with interest...

TO THE EDITOR: I read with interest the article (1) forward bioterrorism agents in the May 1 2003 issue of American Family Physician. This timely piece propounded useful advice to assist family physicians onward an important topic. I would like to attract favor to some information not included in the article.

First, the rule of diagnosis that is described in Table 11 for plague should include cultivation of bubo aspirate (for bubonic plague) in addition to sputum children and cerebrospinal fluid cultures for pneumonic and septicemic plague.

other Table 2 (1) only describes the treatment for inhalational anthrax. There is a separate treatment regimen for cutaneous anthrax. (2) Furthermore, clinicians can consider extending the usual 60-day anthrax prophylaxis to 100 days based forward the possibility that disease may present itself up to 100 days after aspect (3)

DOUG CAMPOS-OUTCALT, MD M.P.A.

Department of Family and Community Medicine

University of Arizona association of Medicine, Phoenix

4001 N Third St #415

Phoenix, AZ 85012

REFERENCES

(1) O'Brien KK Higdon ML Halverson JJ Recognition and management of bioterrorism infections. Am Fam Physician 2003;67:1927-34

(2) Center for Disease bridle and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for position management and antimicrobial therapy, October 2001 (published erratum appears in MMWR Morb Mortal Wkly Rep 2001;50:962) MMWR Morb Mortal Wkly Rep 2001;50:909-19

(3) Center for Disease mastery and Prevention. Additional options for preventive treatment for parts exposed to inhalational anthrax [Notice to readers]. MMWR Morb Mortal Wkly Rep 2001;50: 11421151

IN REPLY: We appreciate Dr Campos-Outcalt's pointing revealed the additional information on bioterrorism infections. He correctly notes that a tillage of bubo aspirate should be done if a bubo is quick in emergencies However, in a bioterrorism attack, parts will be more likely to have pulmonic plague rather than bubonic plague, and this is wherefore we chose not to list this agriculture in Table 1 of our article.1 Cutaneous anthrax treatment is not listed in Table 2 of our article1 because any case of cutaneous anthrax seen during a bioterrorist attack is treated as presum inhalation anthrax until proven otherwise.

KAREN K O'BRIEN, LTC MC USA

8826 Greenleaf Dr

Columbus, GA 31904

The opinions and assertions contained herein are the private views of the authors and are not to be constru as official or as reflecting the views of the U Army Medical Department or the U Army Service at large.

REFERENCE

(1) O'Brien KK Higdon ML Halverson JJ Recognition and management of bioterrorism infections. Am Fam Physician 2003;67:1927-34

COPYRIGHT 2004 American Academy of Family Physicians

COPYRIGHT 2004 Gale Group